SCHEMBL7064360

SCHEMBL7064360

COc1ccc2cc(C(=O)O)c(O)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.52
ALDH1A1 P00352 7/20 0.52
HPGD P15428 4/20 0.52
POLB P06746 3/20 0.52
HSD17B10 Q99714 1/20 0.52
SLC16A3 O15427 1/20 0.51
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ATM Q13315 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HPGDS O60760 3/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA12 O43570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31055812 1.00 KDM4E (0.52) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL2945200 0.84 ALDH1A1 (0.67) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL28532626 0.84 KDM4E (0.52) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL621720 0.83 KDM4E (0.58) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL635539 0.80 PTGS1 (0.52) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL5208343 0.80 ALDH1A1 (0.53) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL14399033 0.79 ALDH1A1 (0.73) KDM4EALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL17967333 0.77 SLC16A3 (0.48) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL7568147 0.77 KDM4E (0.48) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL4496916 0.76 AKR1C3 (0.58) KDM4EALDH1A1HPGDPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030195224-A1 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4- amines and analogs thereof 3M INNOVATIVE PROPERTIES COMPANY 2003-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195224-A1 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4- amines and analogs thereof IFNG, THPO, IL2 KDM4E 1959/4885ALDH1A1 2933/4885HPGD 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.